FI831008L - PYRIDON-2-DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEILING MODEL SOM INNEHAOLLER DEM - Google Patents

PYRIDON-2-DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEILING MODEL SOM INNEHAOLLER DEM

Info

Publication number
FI831008L
FI831008L FI831008A FI831008A FI831008L FI 831008 L FI831008 L FI 831008L FI 831008 A FI831008 A FI 831008A FI 831008 A FI831008 A FI 831008A FI 831008 L FI831008 L FI 831008L
Authority
FI
Finland
Prior art keywords
pyridon
dem
derivatives
foerfarande foer
deras framstaellning
Prior art date
Application number
FI831008A
Other languages
Finnish (fi)
Other versions
FI831008A0 (en
Inventor
Werner Heinrich Myller
Ernst Blume
Rudolf Schleyerbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI831008A0 publication Critical patent/FI831008A0/en
Publication of FI831008L publication Critical patent/FI831008L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI831008A 1982-03-27 1983-03-24 PYRIDON-2-DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEILING MODEL SOM INNEHAOLLER DEM FI831008L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823211395 DE3211395A1 (en) 1982-03-27 1982-03-27 PYRIDON-2 DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME

Publications (2)

Publication Number Publication Date
FI831008A0 FI831008A0 (en) 1983-03-24
FI831008L true FI831008L (en) 1983-09-28

Family

ID=6159523

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831008A FI831008L (en) 1982-03-27 1983-03-24 PYRIDON-2-DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEILING MODEL SOM INNEHAOLLER DEM

Country Status (15)

Country Link
EP (1) EP0090353A1 (en)
JP (1) JPS58174365A (en)
KR (1) KR840004075A (en)
AU (1) AU1287083A (en)
CA (1) CA1193602A (en)
DE (1) DE3211395A1 (en)
DK (1) DK138383A (en)
ES (1) ES8401943A1 (en)
FI (1) FI831008L (en)
GR (1) GR78498B (en)
IL (1) IL68240A0 (en)
NO (1) NO831094L (en)
PH (1) PH19639A (en)
PT (1) PT76449B (en)
ZA (1) ZA832138B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346175A1 (en) * 1983-12-21 1985-07-11 Merck Patent Gmbh, 6100 Darmstadt PYRIDYLTHIOPHENE
FR2665159B1 (en) * 1990-07-24 1992-11-13 Rhone Poulenc Sante NEW PYRIDINE AND QUINOLEIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE4227748A1 (en) * 1992-08-21 1994-02-24 Bayer Ag Pyridyloxy-acrylic acid ester

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents

Also Published As

Publication number Publication date
NO831094L (en) 1983-09-28
ZA832138B (en) 1983-12-28
FI831008A0 (en) 1983-03-24
GR78498B (en) 1984-09-27
JPS58174365A (en) 1983-10-13
PH19639A (en) 1986-06-04
DK138383D0 (en) 1983-03-25
ES520986A0 (en) 1984-01-01
DE3211395A1 (en) 1983-09-29
IL68240A0 (en) 1983-06-15
EP0090353A1 (en) 1983-10-05
CA1193602A (en) 1985-09-17
PT76449A (en) 1983-04-01
PT76449B (en) 1986-01-27
AU1287083A (en) 1983-09-29
DK138383A (en) 1983-09-28
KR840004075A (en) 1984-10-06
ES8401943A1 (en) 1984-01-01

Similar Documents

Publication Publication Date Title
FI834404A0 (en) BETONGTILLSATSMEDEL, SOM OMFATTAR EN FLERKOMPONENTBLANDNING, INNEHAOLLANDE SILIKADAMM, FRAMSTAELLNINGSFOERFARANDE OCH RESULTERANDE BETONGPRODUKT
FI833713A (en) 1-PHENYL-2-PIPERIDINO-PROPANOL DERIVATIVES, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE CEILING MODEL
FI834478A (en) SOM VIRUSLAEKEMEDEL ANVAENDBARA ISOXAZOLER OCH FRAMSTAELLNING AV DEM.
FI833748A0 (en) IMMUNOGENT PROTEIN- ELLER PEPTIDKOMPLEX, SAETT FOER FRAMSTAELLNING OCH ANVAENDNING DAERAV SOM IMMUNSTIMULERANDE MEDEL OCH SAOSOM VACCIN
FI831590A0 (en) AZOLYLMETHYLOXIRANER, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM LAEKEMEDEL
FI830048L (en) ANVAENDNING AV STABILISERADE, PELARFORMADE LEROR I SKIKT SOM KATALYSATORER I REAKTIONER SOM KATALYSERAS AV PROTONER
FI813234L (en) POLYMETHYLENE-4,5, ISOTIAZOLINE-4 ONER-3 DERAS FRAMSTAELLNING OCH ANVAENDNING SOM BAKTERICIDER OCH FUNGICIDER
FI834709A0 (en) SUBSTITUTE FENYLSULFONYLOXIBENZIMIDAZOLKARBAMATER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERANVAENDNING SOM LAEKEMEDELEL
FI832884A (en) DESOXYURIDINDERIVAT, DERAS FRAMSTAELLNINGSFOERFARANDEN OCH ANVAENDNING SOM PHARMACEUTISKA MEDEL
FI841965A0 (en) DIBENZODIAZEPINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI843924A0 (en) ZIRKONIUMOXID-TITANOXID- KISELOXIDTERGELER OCH DERAS ANVAENDNING SOM KATALYSATORBAERARE.
FI842443A (en) 3-PHENYL-4-CYANOPYRROLDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM MIKROBICIDER.
FI842877A (en) ANTRACYKLINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM CYTOSTATER.
FI840822A0 (en) AZOLYLMETHYLCYKLOALKANER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI840588A0 (en) N-SULPHENYLERADE HYDANTOINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM MICROBIZIDER
FI811705L (en) CARBAMOYLOXIAMINO-1,4-BENZODIAZEPINER FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE CEILING MODEL
FI831008A0 (en) PYRIDON-2-DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEILING MODEL SOM INNEHAOLLER DEM
FI833316A0 (en) FOERFARANDE FOER ELIMINERING OCH HINDRANDE AV TILLTAEPPNING AV BOTTENAERATORER, SOM ANVAENDS VID BEHANDLING AV VATTEN OCH AVFALLSVATTEN, UNDER DRIFTSFOERHAOLLANDEN
FI820362L (en) 2-AZOLYLMETHYL-1,3-DIOXOLAN- AND DIOXANDERIVES
FI822586L (en) OXOTIENOBENZOXEPINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI831549L (en) SULFINYL- OR SULFONYL-AZACYKLOHEPTAN-2-ONER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM FODERTILLSATSMEDEL
FI821332L (en) PYRAZOLPYRIDINDERIVAT OCH DERAS FRAMSTAELLNING, ANVAENDBARA SOM HJAERTLAEKEMEDEL
FI842197A (en) ANVAENDNINGSFOERFARANDE OCH ANORDNING SOM UTESTAENGER EN SAMKAELLA.
FI831948A0 (en) MASSKOKNINGSFOERFARANDE OCH KOMPOSITION SOM ANVAENDS I DETSAMMA
FI831370A0 (en) BENZOYLPHENYLUREADERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM PESTICIDER

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT